Volume 19, Issue 75 (4-2011)                   J Adv Med Biomed Res 2011, 19(75): 66-76 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Azarkeivan A, Arjangyan M H, Hajibeigi B, Afradi H, Aghaeepour M, Razjoo F, et al . Evaluasion and Comparison of Washed RBCs by Closed and Open systems. J Adv Med Biomed Res 2011; 19 (75) :66-76
URL: http://journal.zums.ac.ir/article-1-1493-en.html
1- Thalassemia Clinic, Research Center of Iranian Blood Transfusion Organization, Tehran, Iran , azazarkeivan@yahoo.com
2- Thalassemia Clinic, Research Center of Iranian Blood Transfusion Organization, Tehran, Iran
3- Flowcytomery Section, Research Center of Iranian Blood Transfusion Organization, Tehran, Iran
4- Microbiology Lab, Research Center of Iranian Blood Transfusion Organization, Tehran, Iran
5- Quality Control Lab, Research Center of Iranian Blood Transfusion Organization, Tehran, Iran
6- Mofid Children Hospital,Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract:   (165682 Views)

Background and Objective: Leukocyte filters are effective for WBC reduction but they cannot inhibit passing plasma proteins and as a result repeated protein entry may produce allergic transfusion reactions. To deal with this problem, washed RBC method is used. The traditional wash method is an open system through which waste products are carried away in sewers with the risk of environmental pollution. Newly introduced approach for washed RBCs consists of a closed system whereby waste products enter into a bag. In this study, the two methods were compared.
Materials and Methods: The two open and closed wash methods were compared in terms of health system, leukoreduction, risk of transmission of infection and quality control.  In each method, 100 bags were washed, coded and then transmitted to different units of blood culture, flowcytometry as well as quality control. The data were collected and analyzed by SPSS14.
Results: 200 bags (100 for each method) were studied.  Microbiologically, there were no positive results for any of the methods. In quality control also there was not any significant difference in the two methods. In flowcytometry, we didn’t observe any significant correlation in leukocyte count in the two methods before washing (p=0.072), however. The correlation between them after washing (p<0.0001), demonstrating that the new method was better for leukoreduction.
Conclusion: The new washing system method was a superior way because it involves a closed system where waste products are discharged into a side bag and disposed as hospital waste. Meanwhile, this approach is more convenient for leukoreduction. In our country, since we still need a washing system for some transfusions, this method is deemed to be a decent and practical one because it impedes environmental pollution.

Full-Text [PDF 286 kb]   (164905 Downloads)    
Type of Study: Original Research Article |
Received: 2011/06/8 | Accepted: 2014/06/22 | Published: 2014/06/22

References
1. Beatrix W. Clinical management of beta thalassemia major. Semin Hematol. 2001; 38: 350-9. [DOI:10.1016/S0037-1963(01)90029-0]
2. Rund D, Richmilewitz E. Pathophysiology of α and β thalassemia: Therapeutic implication. Semin hematol. 2001; 38: 343-9. [DOI:10.1016/S0037-1963(01)90028-9]
3. Oliveri N. Thalassemia, clinical managment. Bailliers clinic Haematol. 1998; 11: 147-62. [DOI:10.1016/S0950-3536(98)80073-5]
4. Lo L, Singer ST. Thalassemia: current approach to an old disease. Pediatr Clin North Am. 2002; 49:1165-91. [DOI:10.1016/S0031-3955(02)00088-3]
5. Prati D. Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major. Vox Sang. 2000; 79: 129-37. [DOI:10.1046/j.1423-0410.2000.7930129.x]
6. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood. 1994; 84: 1703-21. [DOI:10.1182/blood.V84.6.1703.1703] [PMID]
7. AuBuchon JP, Elfath MD, Popovsky MA, et al. Evaluation of a new prestorage leukoreduction filter for red blood cell units. Vox Sang. 1997; 72: 101-6. [DOI:10.1159/000461970]
8. Higgins VL. Leukocyte-reduced blood components: patient benefits and practical applications. Oncol Nurs Forum. 1996; 23: 659-67.
9. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet. 2007; 370: 415-26. [DOI:10.1016/S0140-6736(07)61197-0]
10. Westphal R. Washed RBC to prevent transfusion reactions. Transfusion. 1982; 22: 82. [DOI:10.1046/j.1537-2995.1982.22182154229.x] [PMID]
11. Jamal R, Mazeni NR, Hussin H. Evaluation of two types of leukocyte removal filters on transfusion dependent thalassaemics. Malays J Pathol. 2000; 22: 79-83.
12. Rabbani A, Azarkeivan A, Farhadi L M, Korosdari Gh. Clinical evaluation of 413 thalassemic patients. J Tehran Faculty Med. 2000; 3: 35-40.
13. Rebulla P. Blood transfusion in beta thalassaemia major. Transfus Med. 1995; 5:247-58. [DOI:10.1111/j.1365-3148.1995.tb00210.x] [PMID]
14. Azarkeivan A, Ahmadi MH, Hajibeigy B, et al. Evaluation of transfusion reactions in thalassemic patients referred to the tehran adult thalssemia clinic. J Zanj Uni Med Sci. 2008; 1: 35-41.
15. Cramber C, Holmberg J, Aman E. Washed aphresis and whole blood derived red cell units: protein and post storage potassium content. Vox sang. 2004; 87(suppl.3): S17-S92.
16. Azarkeivan A. Comprehensive management for thalassemia in Iran. Tehran; Ministry of health, Arvij; 2006.
17. Valeri CR, Pivacek LE, Cassidy GP, Ragno G. The survival, function, and hemolysis of human RBCs stored at 4 degrees C in additive solution (AS-1, AS-3, or AS-5) for 42 days and then biochemically modified, frozen, thawed, washed, and stored at 4 degrees C in sodium chloride and glucose solution for 24 hours. Transfusion. 2000; 40: 1341-5. [DOI:10.1046/j.1537-2995.2000.40111341.x] [PMID]
18. Mintz PD. Transfusion therapy clinical principles and practice. Bethesda, Maryland: AABB Press; 2005.
19. Goodnough LT. Risks of blood transfusion. Anesthesiol Clin North America. 2005; 23: 241-52. [DOI:10.1016/j.atc.2004.07.004] [PMID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb